1. Home
  2. CRCT vs SPRY Comparison

CRCT vs SPRY Comparison

Compare CRCT & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cricut Inc.

CRCT

Cricut Inc.

HOLD

Current Price

$3.99

Market Cap

904.7M

Sector

Industrials

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$8.07

Market Cap

788.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRCT
SPRY
Founded
1969
2015
Country
United States
United States
Employees
N/A
159
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
904.7M
788.5M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
CRCT
SPRY
Price
$3.99
$8.07
Analyst Decision
Strong Sell
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$40.00
AVG Volume (30 Days)
464.0K
1.7M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
22.20%
N/A
EPS Growth
20.69
N/A
EPS
0.10
N/A
Revenue
$708,780,000.00
$84,278,000.00
Revenue This Year
$0.08
$87.40
Revenue Next Year
$0.98
$81.64
P/E Ratio
$39.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.74
$6.66
52 Week High
$7.33
$18.63

Technical Indicators

Market Signals
Indicator
CRCT
SPRY
Relative Strength Index (RSI) 41.10 49.40
Support Level $3.82 $7.82
Resistance Level $4.68 $8.61
Average True Range (ATR) 0.20 0.55
MACD -0.03 -0.04
Stochastic Oscillator 16.05 42.91

Price Performance

Historical Comparison
CRCT
SPRY

About CRCT Cricut Inc.

Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: